We are live on ! Find out more
ZURA icon

Zura Bio
ZURA

35 hedge funds and large institutions have $87.4M invested in Zura Bio in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

9% more capital invested

Capital invested by funds: $80.5M → $87.4M (+$7M)

6% more funds holding

Funds holding: 33 → 35 (+2)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
6
Closed
3
Calls
$167K
Puts
–
Net Calls
+$167K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$4.29M
2
SC
Sculptor Capital
New York
+$1.28M
3
CIM
Cowen Investment Management
New York
+$1.01M
4
WRBC
W.R. Berkley Corp
Connecticut
+$1.01M
5
CS
Clear Street
New York
+$864K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.05M
2
UOC
UBS O'Connor
Illinois
-$2.4M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$1.07M
4
LOAMU
Lombard Odier Asset Management (USA)
New York
-$1.01M
5
HF
HRT Financial
New York
-$398K
Name Holding Trade Value Shares
Change 		Change in
Stake
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$13.3M – – –
MF
2
Magnetar Financial
Illinois
$11.8M – – –
GCL
3
Glazer Capital LLC
New York
$10.2M +$4.29M +423,433 +73%
Marshall Wace
4
Marshall Wace
United Kingdom
$4.97M – – –
SCM
5
Shaolin Capital Management
Florida
$4.59M – – –
BGIM
6
Boussard & Gavaudan Investment Management
United Kingdom
$3.83M – – –
WRBC
7
W.R. Berkley Corp
Connecticut
$3.47M +$1.01M +99,500 +41%
KL
8
KIM LLC
Kansas
$3.06M – – –
OCAM
9
Owl Creek Asset Management
New York
$3.06M – – –
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$3.06M – – –
AGC
11
Angelo Gordon & Co
New York
$2.93M – – –
WCMNY
12
Westchester Capital Management (New York)
New York
$2.59M – – –
RCM
13
Radcliffe Capital Management
Pennsylvania
$2.56M – – –
SC
14
Sculptor Capital
New York
$1.87M +$1.28M +125,985 +221%
PCM
15
Prelude Capital Management
New York
$1.53M – – –
WA
16
Whitebox Advisors
Minnesota
$1.53M – – –
Millennium Management
17
Millennium Management
New York
$1.33M -$3.05M -300,794 -70%
FTCM
18
First Trust Capital Management
Illinois
$1.21M – – –
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.09M – – –
PMAM
20
Picton Mahoney Asset Management
Ontario, Canada
$1.02M – – –
Capstone Investment Advisors
21
Capstone Investment Advisors
New York
$1.02M – – –
CCM
22
Context Capital Management
California
$1.02M – – –
AMC
23
Atlas Merchant Capital
New York
$1.02M +$1.01M +100,000 New
CIM
24
Cowen Investment Management
New York
$1.02M +$1.01M +100,000 New
GF
25
Gabelli Funds
New York
$957K -$151K -14,870 -14%
1
2

ZURA Hedge Fund Activity: Q4 2022 in Review

35 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q4 2022, worth a combined $87.4M — up 8.7% from $80.5M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ZURA positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Glazer Capital LLC, adding an estimated $4.29M. The largest seller was Millennium Management, cutting an estimated $3.05M.

  • 35 institutional investors held Zura Bio (ZURA) as of Q4 2022, up from 33 in Q3 2022.
  • Funds reported $87.4M of Zura Bio stock for Q4 2022, up 8.7% quarter-over-quarter.
  • 5 funds opened new Zura Bio positions in Q4 2022 and 3 closed out, a net change of +2 holders.
  • The largest Zura Bio buyer in Q4 2022 was Glazer Capital LLC, an estimated $4.29M added.
  • The largest Zura Bio seller in Q4 2022 was Millennium Management, an estimated $3.05M sold.

Based on aggregated 13F filings for Q4 2022.